The Board of Directors of the Company at their meeting held on Wednesday, the May 28, 2025 approved the following: 1). Approval of Standalone Audited Financial Results for the quarter ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Microcap 250 and 3.5 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Centenial Surgical Suture Ltd's Board of Directors approved the Standalone Audited Financial Results for the quarter and year ended March 31, 2025, in line with SEBI's Listing Obligations and Disclosure Requirements. The Statutory Auditors issued an Auditor's Report with an unmodified (clean) opinion, indicating no qualifications or adverse remarks on the financials. The company also disclosed Related Party Transactions for the period as required under Regulation 23(9). The board meeting ran from 5:00 PM to 5:35 PM. No specific financial numbers or year-on-year comparisons were shared in this filing.
This is a routine regulatory compliance update. The clean audit opinion is mildly positive for shareholder confidence, while the Related Party Transaction disclosure is standard and shows regulatory compliance rather than any material concern.